Nathan Rich
Stock Analyst at Goldman Sachs
(0.81)
# 3,675
Out of 5,182 analysts
85
Total ratings
34.92%
Success rate
-10.11%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Sell | $215 → $158 | $205.14 | -22.98% | 8 | Feb 17, 2026 | |
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $15.79 | +33.00% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $122.38 | +60.16% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $12.51 | +139.81% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $13.91 | -42.49% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $27.84 | -37.14% | 4 | May 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $23.68 | -40.88% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $32.40 | -66.05% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $190.07 | +18.38% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $589.25 | +10.31% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $77.30 | +13.84% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $21.22 | -43.45% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $78.83 | +7.83% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $14.68 | -25.07% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $148.97 | +124.88% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $324.63 | +64.80% | 5 | Dec 14, 2021 |
Humana
Feb 17, 2026
Maintains: Sell
Price Target: $215 → $158
Current: $205.14
Upside: -22.98%
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $15.79
Upside: +33.00%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $122.38
Upside: +60.16%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $12.51
Upside: +139.81%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $13.91
Upside: -42.49%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $27.84
Upside: -37.14%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $23.68
Upside: -40.88%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $32.40
Upside: -66.05%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $190.07
Upside: +18.38%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $589.25
Upside: +10.31%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $77.30
Upside: +13.84%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $21.22
Upside: -43.45%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $78.83
Upside: +7.83%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $14.68
Upside: -25.07%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $148.97
Upside: +124.88%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $324.63
Upside: +64.80%